In 2013, Japanese government officials implemented the Regenerative Medicine Law to help the country develop new stem cell therapies and regulate their use in order to provide medical patients with the latest medical advancements while ensuring the safety of these practices for the country’s patients. The legislation, which also revised Japan’s previous Pharmaceutical Affairs Law, aimed to establish Japan as a global leader in stem cell research and helped the country to institute a framework that would accelerate the research and development of new regenerative medicine therapies aimed at diseases and medical conditions that were not being treated consistently or with advanced technology. Overall, the legislation’s goal was to speed up the development of regenerative therapies and make them readily available to Japan’s population ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles